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Abstract
Bacteria exist, in most environments, as complex, organised communities of sessile cells embedded within a matrix of self-
produced, hydrated extracellular polymeric substances known as biofilms. Bacterial biofilms represent a ubiquitous and
predominant cause of both chronic infections and infections associated with the use of indwelling medical devices such as
catheters and prostheses. Such infections typically exhibit significantly enhanced tolerance to antimicrobial, biocidal and
immunological challenge. This renders them difficult, sometimes impossible, to treat using conventional chemotherapeutic
agents. Effective alternative approaches for prevention and eradication of biofilm associated chronic and device-associated
infections are therefore urgently required. Atmospheric pressure non-thermal plasmas are gaining increasing attention as a
potential approach for the eradication and control of bacterial infection and contamination. To date, however, the majority
of studies have been conducted with reference to planktonic bacteria and rather less attention has been directed towards
bacteria in the biofilm mode of growth. In this study, the activity of a kilohertz-driven atmospheric pressure non-thermal
plasma jet, operated in a helium oxygen mixture, against Pseudomonas aeruginosa in vitro biofilms was evaluated.
Pseudomonas aeruginosa biofilms exhibit marked susceptibility to exposure of the plasma jet effluent, following even
relatively short (,109s s) exposure times. Manipulation of plasma operating conditions, for example, plasma operating
frequency, had a significant effect on the bacterial inactivation rate. Survival curves exhibit a rapid decline in the number of
surviving cells in the first 60 seconds followed by slower rate of cell number reduction. Excellent anti-biofilm activity of the
plasma jet was also demonstrated by both confocal scanning laser microscopy and metabolism of the tetrazolium salt, XTT,
a measure of bactericidal activity.
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Introduction
Microbial biofilms are organised, multicellular communities
held together by a self-produced matrix forming architecturally
complex structures [1–3]. Biofilms are ubiquitous in both natural
and pathogenic ecosystems [4] and may be present on almost
every biotic or abiotic surface or interface [2]. The process of
biofilm formation begins with cellular attachment to a substratum,
and formation of microcolonies on the surface, which become
embedded within a self-produced extracellular, hydrated matrix
and which subsequently differentiate into a mature biofilm, These
exhibit architecturally defined, complex three-dimensional struc-
tures and a functionally heterogeneous bacterial population [4,5].
Dispersal mechanisms facilitate colonisation of new niches [2],
including repopulation of surfaces following sub-lethal antimicro-
bial challenges.
Biofilms are estimated to be implicated in around 80% of all
chronic human infections [6] and are important mediators of
healthcare-associated infections [7], around half of which are
related to the use of an indwelling medical device [8]. In 2008,
more than 4 million patients acquired healthcare-associated
infections in European hospitals; which resulted in about 37000
deaths as a direct consequence [7]. In the US, the number of such
infections was more than 1.7 million in 2002 with almost 100,000
associated deaths [9]. Infections related to medical devices were
the first clinical infections to be identified as having biofilm
aetiology [5,10]. With many millions of medical devices being used
each year [11], biofilms constitute a significant public health risk
for patients requiring such devices [12]. Among these devices are:
intravenous catheters, prosthetic heart valves, joint prostheses,
peritoneal dialysis catheters, cardiac pacemakers, cerebrospinal
fluid shunts, urethral catheters, urinary stents and endotracheal
tubes, which all have an intrinsic risk of surface-associated
infections [5]. Biofilms have also been associated with many other
conditions, on biotic surfaces, including dental plaque, upper
respiratory infections, peritonitis, and urogenital infections [11].
Biofilms constitute a protected mode of bacterial growth [2] and
bacteria within biofilms typically exhibit significantly enhanced
tolerance to antimicrobial challenge and host defences, compared
to planktonic bacteria of the same species [2,5,13–15]. Indeed,
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bacteria in biofilms can be up to a thousand times more resistant
to antimicrobial challenge than the planktonic cells of the same
species [16,17]. This recalcitrance to antimicrobial challenge can
explain why biofilm-mediated infections often fail to respond to
conventional antibiotic treatment regimens [14]. Many mecha-
nisms of biofilm resistance to antimicrobial agents have been
proposed; a first mechanism is the failure of antimicrobial agents
to penetrate into the whole structure of the biofilm as a result of
the barrier properties offered by the polymeric matrix [2,5,13].
Another mechanism explaining biofilm resistance is that a large
number of microorganisms within a biofilm experience nutrient
depletion which renders them slow-growing or metabolically
inactive [2,13]. Most antimicrobials require at least some degree of
cellular activity to be effective; since their mechanism of action
usually relies on disrupting different microbial metabolic processes
[5]. The third mechanism, of biofilm resistance, is related to the
presence of subpopulations that exhibit distinct resistant pheno-
types [2,5]. These subpopulations are frequently referred to as
‘‘persister cells’’ [18,19].
Pseudomonas aeruginosa is an opportunistic Gram negative
pathogen. The ability of this pathogen to survive in multiple
niches and to utilize many naturally occurring compounds as
energy sources makes it one of the most ubiquitous bacteria in
both the environment and the clinical setting, where it contam-
inates the floor, bed rails, and sinks, and the skin of patients and
healthcare personnel [20]. Unsurprisingly, in the European
Prevalence of Infection in Intensive Care Study, this bacterium
was found to be responsible for up to 28% of nosocomial infections
in intensive care units [21]. The majority of these infections were
found to affect immunocompromised patients or those having
severe underlying diseases like cystic fibrosis and severe burns in
addition to those who are in contact with contaminated medical
devices [21]. Unfortunately, such nosocomial infections are
frequently life threatening and often challenging to treat; especially
with the frequent emergence of resistance to multiple drugs in this
pathogen [22]. This resistance can emerge gradually during
exposure to antipseudomonal antibiotics [23], this emergence was
reported in 27–72% of patients with initially susceptible P.
aeruginosa isolates and usually results in higher morbidity, mortality
and economic burden [22].
As an antimicrobial strategy, atmospheric pressure non-thermal
plasmas benefit from simple design, relatively low capital and
operational cost [24], utilisation of non-toxic gases [25], operating
at gas temperatures at or near room temperature [24–26], and the
absence of harmful residues [24]. Importantly, these plasmas
produce large quantities of microbicidal active agents [27]; which
include a mixture of charged particles (positive and negative ion
and electrons), chemically reactive species, UV radiation and
electromagnetic fields [28]. The diversity and the small size of
these active agents are believed to target multiple cellular
components and metabolic processes in microorganisms and
therefore make the emergence of resistance mechanisms less likely.
The exact mechanisms driving plasma-mediated bacterial
inactivation are not yet well understood [29,30]. However, several
plasma products are believed to play a role in this process, these
products include reactive oxygen species (ROS) [29–31], reactive
nitrogen species (RNS) [31], ultraviolet radiation (UV) [30] and
charged particles [30]. Among the ROS believed to be involved in
this process are ozone, atomic oxygen, single delta oxygen,
superoxide, peroxide, and hydroxyl radicals [30,32]. Although
many of the aforementioned ROS have documented antibacterial
activities through their interactions with different cellular compo-
nents [30,33,34], it is highly important to consider the additive and
synergistic effects of these species with each other’s and with other
plasma products like UV radiation and charged particles, in such a
physically and chemically complex environment, before any
successful conclusions can be drawn about the responsible cellular
inactivation processes.
The use of atmospheric pressure non-thermal plasmas has been
evaluated for a number of biomedical applications, including:
wound healing [26,35], blood coagulation [35,36], skin regener-
ation [35], tooth bleaching [36], and apoptosis of cancer cells
[35,36]. In addition, many atmospheric pressure plasma systems
have been studied and proven to be effective in terms of microbial
inactivation and even surface decontamination and sterilization
[24,26,35–38]. However, most of these studies have been carried
out using planktonic bacteria, which do not represent the entire
spectrum of bacterial growth and survival in the natural as well as
clinical settings. Whilst a number of studies have examined the
effect of atmospheric pressure non-thermal plasmas on microbial
biofilms [39–47], this study presents a comprehensive investigation
of the activity of an in-house designed kHz-driven atmospheric
pressure non-thermal plasma jet for the in vitro eradication of the
clinically significant P. aeruginosa biofilms grown on inanimate
surfaces. Multiple approaches were adopted to evaluate the
bacterial cell viability prior to and after plasma treatment. These
approaches are based on colony count method, XTT assay and
LIVE/DEAD differential staining followed by confocal laser
scanning microscopy. Furthermore, the effect of changing the
plasma operating frequency on the anti-biofilm activity of the
plasma jet was also investigated. Although the exact explanation
for the difference in plasma activity upon changing the frequency
was not provided in this manuscript since it needs further
investigations, to our knowledge, this is the first research paper
to date to report the effect of changing the frequency, within the
same jet configuration, on biofilm eradication by plasma; which
adds useful information about tailoring this approach to suit
different biofilm-related applications.
Materials and Methods
Bacterial Strain(s) & Growth Conditions
Pseudomonas aeruginosa PA01 (ATCC BAA-47, obtained from the
American Type Culture Collection) was stored at 270uC in
Microbank vials (Pro-Lab Diagnostics, Cheshire, UK) and was
subcultured in Mu¨ller-Hinton Broth (MHB) several times prior to
conducting the microbiological assessments.
Plasma Source
A schematic diagram and a photograph of the plasma jet used
in this study, as previously described in [43,48], are presented in
Figure 1. It consists of a quartz tube with inner and outer
diameters of 4 mm and 6 mm, respectively. Two copper
electrodes (2 mm wide) encircle the tube, separated by 25 mm.
For the experiments presented here the output of a high voltage
pulse source (Haiden PHK-2k), operating at variable repetition
frequencies, of between 20 and 40 kHz, and voltage amplitude
6 kV, is applied to the downstream electrode, which is 5 mm from
the end of the plasma tube. The upstream electrode is grounded.
The plasma jet was operated with a gas mixture of 0.5% oxygen
and 99.5% helium, at a total flow rate of 2 Standard Litres per
Minute (SLM) into ambient air. This plasma jet can be observed to
generate an intense core plasma between the two electrodes and a
luminous plume, which under the operating conditions discussed
here, extends up to several centimetres beyond the exit of the tube.
Spatially and temporally resolved images in the main plasma
production region and plume regions confirm the presence of
P. aeruginosa Biofilms Removal by APNTP
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streamer-like behaviour ([48–52], which is in good agreement with
the model proposed by Lu and Laroussi [49].
Inhibition Zone Determination
Inhibitory zones formed on P. aeruginosa lawns on solid agar
cultures following exposure to the plasma plume were determined
as described previously [43]. After exposure to the plasma,
Mueller Hintonagar (MHA) plates which had been streaked with a
phosphate buffered saline-diluted overnight culture of P. aeruginosa
were incubated at 37uC for 24 hours in a static incubator and the
diameter of zones of inhibition measured using Vernier callipers.
Biofilm Growth
For survival curves construction and XTT assay experiments,
bacterial biofilms were grown on the peg lid of Calgary Biofilm
Device (commercially available as the MBEC AssayTM for
Physiology & Genetics (P & G), Innovotech Inc., Edmonton,
Alberta, Canada). An overnight culture of PA01 was adjusted to
an optical density (OD550) equivalent to 1610
7 cfu/ml. The
standardized bacterial suspension was used to inoculate the
Calgary Biofilm Device (with 150 ml in each well) which was then
incubated at 37uC for 48 hours in a humidified compartment
within an orbital incubator. The bacterial inoculum was replaced
by fresh growth medium (i.e. MHB) after the first 24 hours of
incubation. At the end of 48 hours of incubation, individual pegs
were broken off the lid with sterile pliers and gently rinsed with
200 ml of PBS for 1 minute to get remove of any planktonic or
loosely adhered bacteria before exposure to the plasma jet.
For microscopic examination, bacterial biofilms were grown on
polycarbonate coupons (10 mm diameter) in a continuous flow cell
chamber (FC 271-AL-3610 Dual Channel Coupon Evaluation
Flow Cell, BioSurface Technologies Corp., Bozeman, Montana,
USA) for 3 days. Initially, fresh growth Mueller Hinton broth
(MHB) was allowed to perfuse the flow cell at a rate of 0.1 ml/
minute for 24 hours, after which time the perfusion was arrested
and 1 ml of a mid-logarithmic phase bacterial suspension was
injected into the flow cell chamber and left for 1 hour (under static
conditions) to allow for adherence of bacterial cells onto the
coupon surface. Following cell adherence, the flow cell chamber
was perfused with fresh MHB at a rate of 0.1 ml/minute for 3
days. At the end of the biofilm growth period, a final rinsing step
was carried out by running 0.9% NaCl solution through the flow
cell at a rate of 1.0 ml/minute for 10 minutes before removing the
coupons bearing mature biofilm, using sterile surgical tweezers,
and exposure to the plasma treatment.
Treatment Conditions
Individual pegs, bearing 48 hr PA01 biofilms, were exposed to
the plume of the plasma jet for varying periods of time (0, 15, 30,
45, 60, 120, and 240 seconds) as described previously [43]. The
treatment was repeated in triplicate at each time point. The
distance between the end of the plasma tube and top of the peg
was fixed to 15 mm. The atmospheric pressure plasma jet was
operated at a frequency of either 20 or 40 kHz at a set voltage of
6 kV. For determining bacterial inhibition zones resulting from
plasma exposure, the bacteria seeded agar plates were placed
under the plasma plume at a distance of 25 mm away from the
end of the plasma tube for the following time intervals: 0, 120, and
240 seconds. After plasma exposure, the plates were incubated and
photographed as mentioned previously. Mature biofilms grown on
polycarbonate coupons in the flow chamber described above were
exposed to the 20 kHz plasma jet under the same operating
conditions but at two time points (60 seconds and 240 seconds). In
Figure 1. The plasma jet used in this study. (A) Schematic diagram of the plasma jet. (B) Photograph of the plasma jet interacting with a biofilm
sample.
doi:10.1371/journal.pone.0044289.g001
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addition, a gas-only exposure (with the power supply switched off)
was carried out as a control.
Cell Viability Determination
After plasma exposure, the pegs were replaced in the wells of a
96-well Microtiter plate containing 200 ml PBS in each well and
sonicated [17] for 10 minutes in order to dislodge the biofilm cells
from the pegs and to re-suspend surviving bacteria in PBS to
permit viable counting. Following sonication, the pegs were
discarded and the resultant bacterial suspensions were used to
determine the viability of surviving bacterial cells.
After bacterial biofilm exposure to the plasma jet, the viability of
surviving cells was quantitatively determined using two methods:
standard colony count method and XTT viability assay. In the
standard colony count method, the recovered bacterial suspen-
sions were 10-fold serially diluted in a 96-well microtiter plate
using sterile PBS, and three aliquots (20 ml each) from each well
were spotted on the surface of MHA plate. After incubating the
MHA plates at 37uC for 24 hours, the number of colonies
originated from each spot was counted using a colony counter.
The number of surviving cells was calculated as colony forming
unit per peg (cfu/peg) and survival curves were constructed based
on these values. Furthermore, percentage cell killing was
calculated by comparing the number of surviving cells in each
sample with the number of bacterial cells present in the untreated
samples (zero exposure time) prepared under the same conditions.
XTT viability assay (XTT based in vitro Toxicology Assay Kit,
Sigma-Aldrich Company Ltd., Dorset, UK) was carried out as
follows: an XTT stock solution was prepared by reconstituting a
kit vial (containing 5 mg of XTT with 1% PMS) with 5 ml of PBS.
50 ml aliquots of the recovered bacterial suspensions (after plasma
exposure) were transferred into the wells of a 96-well microtiter
plate containing 50 ml of growth media (MHB), and then 20 ml of
the XTT stock solution was added to each well. After incubating
the microtiter plate at 37uC for 5 hours in an orbital incubator, the
absorbance at 450 nm was measured, against blank controls
(containing 50 ml PBS, 50 ml MHB, and 20 ml XTT solution),
using a plate reader (BioTek EL808 Microplate Reader, BioTek
UK, Bedfordshire, UK) in order to quantify XTT metabolic
product, the intensity of which is proportional to the number of
respiring cells. The percentage cell killing at each time point was
calculated by comparing the absorbance of the samples repre-
senting that time point with the absorbance representing the
untreated control samples.
Confocal Scanning Laser Microscopy
Following exposure of the biofilms grown on polycarbonate
coupons to the plasma jet, biofilms were stained with LIVE/
DEAD BacLightBacterial Viability Kit (Molecular Probes, Eu-
gene, OR, USA), and examined by confocal laser scanning
microscope (Leica TCS SP2 Confocal Microscope, Leica Micro-
systems, UK). Z-stacks of confocal images were rendered into 3D
mode using Volocity software (PerkinElmer, UK).
Results and Discussion
Bacterial Growth Inhibition Zones
In order to visually demonstrate the effect of the investigated
atmospheric pressure plasma jet on the viability of bacterial cells,
MH agar plates seeded with P. aeruginosa were exposed to the
plasma plume and incubated overnight. As shown in Figure 2, the
plasma-exposed plates showed significant bacterial inhibition
zones which indicate the extent of bactericidal activity of the
plasma jet, against planktonic P. aeruginosa spread over the surface
of the agar.
Although the maximum diameter of the plasma plume observed
in the current jet is less than 5 mm, inhibition zones of several
centimetres are obtained; which indicates that plasma-derived
active species are not confined within the visible plasma plume,
rather they are present in a larger volume around it. The
observable inhibition zone diameter increased with increasing
exposure time. This is most likely due to decreasing densities of the
active bactericidal species as a function of distance from the centre
of the visible plasma plume, as these species interact with
components of ambient air. Therefore areas at the periphery of
the inhibition zone would be expected to require longer exposure
times in order to inactivate the bacteria present.
Biofilm Eradication by 20 kHz Plasma and Its Survival
Curve
In biofilm eradication studies, the plasma jet under investiga-
tion, operated at 20 kHz and 6 kV produced more than 4-log
(99.99%) reduction in the number of viable cells of P. aeruginosa
biofilm within 4 minutes of exposure, as shown in Figure 3. In an
Figure 2. Bacterial growth inhibition zones. P. aeruginosa cell suspensions were spread over MHA plates (9 cm in diameter). The seeded plates
were exposed to the 20 kHz plasma jet for (A) 0 s, (B) 120 s, and (C) 240 s and then incubated at 37uC for 24 hours. After incubation, photographs of
agar plates, showing bacterial growth inhibition zones, were taken using a digital camera.
doi:10.1371/journal.pone.0044289.g002
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earlier short communication, we observed complete eradication of
P. aeruginosa biofilms after 10 minutes of exposure using the same
plasma jet operating at 20 kHz and 6 kV [43]. These results are
superior to those reported for other atmospheric pressure plasma
jets against various Gram negative bacterial biofilms; where less
than a 2-log (99%) reduction was achieved in 4 minutes with
Chromobacterium violaceum [39] and Neisseria gonorrhoeae [53] biofilms.
In another study, only 40 fold reduction in the number of E. coli
biofilm cells was achieved after 40 minutes of exposure to another
setup of atmospheric pressure plasma [41], even though E. coli
biofilms had been reported to be more susceptible, toward the
plasma jet investigated in this study, than P. aeruginosa biofilms
[43]. Treatment of fungal biofilms using three different plasma
systems was also reported in [46]; where the most efficient system
showed 5-log reduction after 10 minutes of plasma exposure, but
complete biofilm eradication was not achieved with any of the
three plasma systems [46].
On the other hand, activity of a radiofrequency plasma needle
was evaluated against Streptococcus mutans biofilms [44]. Although
this plasma needle was shown to have a good activity against
biofilms, grown under certain conditions, no enumeration of
surviving biofilm cells was carried out in this study. In another
study, microwave-induced argon plasma has been shown to
completely eradicate E. coli, S. epidermidis and MRSA biofilms after
20 seconds of exposure [45], but quantitative analysis of biofilm
surviving cells was based on crystal violet (CV) assay. While CV
assay is a good indicator of the total attached biomass, it is poorly
suited to evaluate killing of biofilm cells [54,55]. In a recent study,
oral biofilms formed in situ on titanium discs were removed by
microwave-driven nonthermal plasma, however, ‘‘complete re-
moval’’ was only achieved after another treatment with air/water
spray followed by a second cycle of plasma treatment [47].
Although these three studies present valuable information on the
use of atmospheric pressure plasma for biofilm eradication, no
survival curves or log-reduction values were reported which makes
it hard to compare the efficiencies of these plasma systems with
that of the system being investigated in the current study.
The survival curve presented in Figure 3 is characterised by a
biphasic trend in which there are two bacterial inactivation phases;
each with a distinct decimal reduction time (D-value, the time
taken to reduce the bacterial population by 90% or a one log
reduction). The first phase occurring during the initial 60 seconds
of plasma exposure is characterised by a rapid reduction in the
number of surviving cells with a D-value of 23.57 seconds. After 60
seconds of exposure, a second inactivation phase starts with a
lower rate of bacterial destruction reflected by a higher D-value of
128.20 seconds. These data concur with similar biphasic survival
curves reported for Chromobacterium violaceum [39] and Neisseria
gonorrhoeae [53] biofilms, on exposure to different setups of
atmospheric pressure plasma. The slower rate of biofilm reduction
observed after 60 seconds of plasma exposure may result from the
protection provided by the polymeric matrix surrounding cells in
deep layers of the biofilm, or may be caused by the shielding effect
of cellular debris produced from the plasma-lysed cells at the
surface of biofilms, as previously proposed [39].
Effect of Plasma Frequency Variation on Its Anti-biofilm
Activity
As discussed above the kHz-driven plasma jet used in this study
produces a pulsed plasma jet or ‘plasma bullets’ rather than a
continuous plasma plume [48,49,56]. Thus a higher frequency
results in more plasma pulses and effective plasma on-time; hence
on time average a higher density of the plasma reactive species will
be delivered [57]. It would therefore be expected that increasing
the frequency (in this case, by a factor of 2, from 20 kHz to
40 kHz) would yield improved plasma-mediated biofilm eradica-
tion by increasing the effective plasma ‘dose’ delivered. Figure 4
demonstrates that 40 kHz plasma resulted in a significantly
enhanced inactivation rate of P. aeruginosa biofilms, with complete
biofilm eradication after only 4 minutes of plasma exposure. This
would indicate that biofilm inactivation by atmospheric pressure
plasma is ‘dose’ dependent, besides being time dependent.
Through varying the plasma pulse repetition rate, at a constant
applied voltage, we can increase the dissipated power into the
plasma, while E/N remains unchanged. However, it is also
important to consider the recombination chemistry of the plasma
afterglow since the biofilm is exposed to the time averaged plasma.
Species have varying lifetimes and some species densities will
increase, while others will dramatically decrease in the plasma-off
phase. Metastable molecular singlet delta oxygen (SDO) is an
important ROS and known agent in numerous biochemical
processes, it also has an extremely long radiative lifetime of more
than 75 minutes in the gas phase. The absolute density of SDO, as
measured through infra-red emission spectroscopy in the same
plasma source, while in general increases with increasing
frequency, between 20 kHz and 40 kHz remains constant at
Figure 3. Survival curve of biofilm treated with 20 kHz plasma.
48-hour P. aeruginosa biofilms, grown on Calgary Biofilm Device, were
exposed to the 20 kHz plasma jet for up to 4 minutes. The number of
biofilm surviving cells in each sample was then calculated using colony
count method and used to construct the log survival curve. (Each point
represents the mean of 3 values 6 SE).
doi:10.1371/journal.pone.0044289.g003
Figure 4. Survival curves of biofilms treated with 20 kHz vs.
40 kHz plasma. Comparison between log survival curves of P.
aeruginosa biofilm cells, constructed as described above, upon
exposure to both 20 kHz and 40 kHz plasma jet. (Each point represents
the mean of 3 values 6 SE).
doi:10.1371/journal.pone.0044289.g004
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261014 cm-3 [32]. Since the measured gas temperature in the
plasma increases with pulse repetition rate we might expect a
reduction in ozone density; the dependence of ozone density on
gas temperature is well known. With increasing gas temperature,
the ozone production rate decreases and its destruction rate
increases, both leading to a lower ozone density [58]. From this we
can conclude that the mechanisms responsible for enhanced
biofilm inactivation with pulse repetition rate are complex and it
probably not solely an individual species responsible.
The survival curve for the 40 kHz plasma also exhibits a
biphasic behaviour similar to the 20 kHz plasma but with lower
D-values of 15.97 seconds and 69.79 seconds for the first and the
second inactivation phases, respectively, compared to 23.57 and
128.20 seconds for 20 kHz (Table 1). A noteworthy point related
to the D-values is that doubling the operating frequency from
20 kHz to 40 kHz resulted in reducing the D-value of the second
phase by almost half.
Unfortunately, doubling the plasma operating frequency
increased not only the dose of active species delivered by the
plasma but also the gas temperature of plasma discharge. While
the 20 kHz plasma plume exhibited a gas temperature, measured
as described by [59], around 39uC, at 40 kHz the gas temperature
of the plasma jet was about 57uC. Although measuring the ‘‘local
biofilm temperature’’ would be an interesting way of studying its
effect in the eradication process, the determination of this
temperature is not practically feasible because of the micro nature
of bacterial biofilms. Nevertheless, since the biofilm is exposed to
the plasma in an open ambient environment and under a
continuous plasma gas flow, it is less likely that local temperature
of the exposed biofilm will significantly exceed that of the plasma
gas temperature. However, the higher temperature, observed at
40 kHz, may limit potential applications of this discharge when
operating at such higher frequencies, especially for heat sensitive
materials and viable tissues, but further modifications of this
discharge setup, that may reduce its gas temperature, could
overcome this issue.
Cell Viability Determination by XTT Assay
The XTT assay has been frequently used for the quantification
of bacteria and bacterial biofilms [42,60] where it detects the
presence of cells that are viable and metabolically active [42]
regardless of being culturable. The viability of P. aeruginosa biofilms
treated with a 20 kHz plasma discharge was evaluated using this
method. After the samples had been prepared, as previously
described, absorbance at 450 nm was measured to quantify the
presence of orange-coloured formazan product which results from
XTT reduction by metabolically active cells, to estimate the
number of surviving cells. Absorbance values (at 450 nm)
measured after exposing P. aeruginosa biofilms to the plasma jet
for different time intervals are presented in Figure 5. The values
continuously drop with increasing the time of plasma exposure to
reach almost nil after 60 seconds which indicates the continuous
reduction in the number of surviving cells upon plasma exposure.
This supports the evidence for the inactivation effect exhibited by
the plasma against the bacterial biofilm. Percentage cell reduction
values calculated based on XTT assay show good correlation with
those obtained by the colony count method (Figure 6). One major
difference between results of the two methods lies in the 15-
seconds exposure point; the colony count method indicates that
85% cell killing was achieved at this point, while the value was
about 36% from the XTT assay results. This finding may indicate
that plasma exposure for this period of time provides a sub-lethal
Table 1. D-values of 20 kHz and 40 kHz plasma jets against
P. aeruginosa biofilm cells.
D-Value (sec)
Operating Frequency Phase 1 Phase 2
20 kHz 23.57 128.20
40 kHz 15.97 69.79
doi:10.1371/journal.pone.0044289.t001
Figure 5. Absorbance of XTT-assay product. 48-hour P. aeruginosa
biofilms, grown on Calgary Biofilm Device, were exposed to the 20 kHz
plasma jet for up to 4 minutes. After plasma exposure, bacterial cells
were dislodged off the pegs into PBS buffer by sonication. 50 ml
aliquots of the recovered bacterial suspensions were then mixed with
50 ml of MHB and 20 ml of XTT stock solution and incubated at 37uC for
5 hours. After incubation, the absorbance at 450 nm was measured to
quantify XTT metabolic product, the intensity of which is proportional
to the number of viable (respiring) cells. (Each point represents the
mean of 3 values 6 SE).
doi:10.1371/journal.pone.0044289.g005
Figure 6. Percentage cell reduction curves based on colony
count method vs. XTT assay. Percentage cell reduction curves of
P. aeruginosa biofilm cells upon exposure to the 20 kHz plasma jet. The
dotted line is based on the standard colony count method whereas the
solid line is based on the XTT assay. (Each point represents the mean of
3 values 6 SE).
doi:10.1371/journal.pone.0044289.g006
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dose which may render some of the biofilm cells non-culturable
but still viable, which was also referred to in [39].
Live/Dead Staining and Confocal Microscopy
Examination
In addition, P. aeruginosa biofilms were stained with Live/Dead
BacLight bacterial viability staining kit for examination by
confocal laser scanning microscope. The viability kit consists of
two dyes; green-fluorescent SYTO 9 which stains live bacteria,
and red-fluorescent propidium iodide which only penetrates non-
viable bacterial cells with damaged/perturbed cell membranes.
The 3D rendered confocal images of the plasma exposed biofilms,
presented in Figure 7 further supports the findings of the other
experiments, namely the biofilm viable counting and XTT assays.
While unexposed biofilm has been shown to be predominantly
green (viable), the fraction of red colour (non-viable) increased
upon increasing plasma exposure time such that the 240 s plasma
exposed biofilm was almost entirely stained red; indicating that
vast majority of biofilm cells were by then rendered non-viable.
On the other hand, the maximum biofilm thickness observed in
the biofilm areas examined by the confocal microscope was
between 40 mm and 80 mm. After 240 s plasma exposure, cells in
the whole biofilm thickness were affected which indicates the
ability of the active plasma species to penetrate deeply into the
biofilm and inactivate the cells within.
Conclusions
In this study a kHz-driven cold atmospheric pressure plasma jet
has proven to be highly efficient in the in vitro inactivation of
P. aeruginosa biofilms. A greater than 4-log (99.99%) reduction in
the number of viable cells was achieved within 4 minutes of
exposure to the plasma jet when operated at 20 kHz. While
increasing the operation frequency to 40 kHz resulted in a
complete eradication of the bacterial biofilm at 4 minutes. Survival
curves, under both operating frequencies, exhibit a biphasic trend
with a rapid decline in the number of surviving cells in the first 60
seconds followed by a slower rate of bacterial cell inactivation.
Percentage cell reduction values obtained by XTT assay were,
generally, in agreement with those obtained by colony count
method with an exception at the early stage of exposure, this
difference might suggest the presence of complex changes in cell
physiology prior to their complete destruction. Confocal micros-
copy examination, preceded by a differential staining with LIVE/
DEAD BacLight Bacterial Viability Kit, has supported the
evidence of the bacterial inactivation effect exerted by the plasma
jet through the whole thickness of P. aeruginosa biofilms. Plasma
reactive species are highly reactive and relatively short-lived;
although they have proven to exert an activity through full
thickness of the bacterial biofilm, they are not expected to
penetrate a host tissue or a thick substance. Therefore, the plasma
application suggested by this study lies within the area of surface
decontamination/sterilisation and not intended to cover biofilms
protected by thick living tissues or growing in body cavities.
On the other hand, the comparison between plasma-induced
effects at the two frequencies is difficult since the gas temperature
in the plasma plume increased with frequency. More detailed
measurements are required in order to quantify specific plasma
species for an improved understanding of the plasma environment.
Although a comprehensive and systematic understanding of the
mechanisms underlying biofilm eradication and bactericidal
activity by atmospheric pressure non-thermal plasmas will prove
necessary for the translation of this technology to clinical
applications, atmospheric pressure non-thermal plasmas would
appear to offer a promising, novel and highly efficient strategy for
the control of microbial biofilms on inanimate surfaces, such as
biomaterials employed in the manufacture of indwelling medical
devices, as well as viable tissues.
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Figure 7. CLSM images of the plasma treated biofilms. 3D rendered confocal laser scanning micrographs of 3-day P. aeruginosa biofilms,
grown on polycarbonate coupons, exposed to the 20 kHz plasma jet for 0s (A and D), 60 s (B and E), and 240 s (C and F). Green colour indicates
surviving cells whereas red colour indicates dead cells. Magnification power is 200x (a-c) and 600x (d–f).
doi:10.1371/journal.pone.0044289.g007
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